OnabotulinumtoxinA X
Sponsors
Allergan
Conditions
Forehead LinesGlabellar Lines
Phase 2
A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
CompletedNCT05100199
Start: 2021-10-06End: 2022-12-02Updated: 2025-09-09
A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead Lines
CompletedNCT05152576
Start: 2021-11-29End: 2022-09-06Updated: 2025-07-16